These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Health research at educational institutions: costs and accountability. The view from where the Department of HHS Inspector General sits. Lowe RB Fed Proc; 1980 Nov; 39(13):7a-10a. PubMed ID: 6775983 [No Abstract] [Full Text] [Related]
6. Determining the costs of journals used in support of federally sponsored research. McKeehan NC Bull Med Libr Assoc; 1984 Apr; 72(2):147-9. PubMed ID: 6733324 [TBL] [Abstract][Full Text] [Related]
7. Cost accounting key to capitated contracts. Fulton RE Diagn Imaging (San Franc); 1997 Nov; 19(11):101-5. PubMed ID: 10176112 [No Abstract] [Full Text] [Related]
8. Clinical research in cancer: a time for consensus. Oldham RK Mol Biother; 1989; 1(5):242-3. PubMed ID: 2619944 [No Abstract] [Full Text] [Related]
9. The indirect costs of sponsored research. Cooper AD Clin Res; 1984 Apr; 32(2):99-105. PubMed ID: 6713806 [No Abstract] [Full Text] [Related]
11. Federal requirements for performing cost analysis of a contract proposal. Powers RJ Grants Mag; 1984 Mar; 7(1):65-70. PubMed ID: 10270261 [No Abstract] [Full Text] [Related]
12. The future of biomedical research. Gottschalk CW N C Med J; 1979 Aug; 40(8):501-4. PubMed ID: 291786 [No Abstract] [Full Text] [Related]
13. Productivity of sustained research funded by the Medical Research Council of New Zealand during the period 1973-84. Lee D N Z Med J; 1988 Feb; 101(839):55-7. PubMed ID: 3380427 [TBL] [Abstract][Full Text] [Related]
14. Indirect cost rates. What they are and how they reached their current levels. McLoughlin WJ; Parker MG Cancer Invest; 1990; 8(5):541-6. PubMed ID: 2265376 [No Abstract] [Full Text] [Related]
15. New estimates of drug development costs. Frank RG J Health Econ; 2003 Mar; 22(2):325-30. PubMed ID: 12606149 [No Abstract] [Full Text] [Related]